Tonia Studer
Family · Mansfield, OHNPI 1457733867
Payments from drug & device makers
Across 72 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$322
- AstraZeneca$286
- GSK$113
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$74
- Exact Sciences$56
- Johnson & Johnson$54
- plus $342 from 14 others
What the payments were for
- Food & beverage$1,247100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $322 |
| AstraZeneca | 12 | $286 |
| GSK | 7 | $113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $74 |
| Exact Sciences | 3 | $56 |
| Johnson & Johnson | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Novo Nordisk | 2 | $32 |
| Pfizer | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Viiv Healthcare Company | 1 | $20 |
| Merck | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $12 |
| Dexcom, Inc. | 1 | $12 |
How this compares
$1,247 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 52 | $74,459 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 67 | $66,637 |
| XifaxanRifaximin | 16 | $51,709 |
| FarxigaDapagliflozin Propanediol | 50 | $46,176 |
| JardianceEmpagliflozin | 31 | $45,546 |
| OzempicSemaglutide | 22 | $34,212 |
| EliquisApixaban | 34 | $27,258 |
| TradjentaLinagliptin | 23 | $20,638 |
| Spiriva HandihalerTiotropium Bromide | 21 | $19,088 |
| Spiriva RespimatTiotropium Bromide | 21 | $18,240 |
| MounjaroTirzepatide | 11 | $15,578 |
| JanuviaSitagliptin Phosphate | 23 | $15,558 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $14,981 |
| SymbicortBudesonide/Formoterol Fumarate | 49 | $14,343 |
| Breo ElliptaFluticasone/Vilanterol | 23 | $13,219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $286 | $127,155166 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $36 | $90,03763 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $12 | $84,42375 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $74 | $51,70916 claims |
| Novo NordiskOzempic | $32 | $34,21222 claims |
| MerckJanuvia, Janumet | $15 | $30,53937 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta | $113 | $28,51051 claims |
| PfizerEliquis | $22 | $27,25834 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.
Other family in Mansfield
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.